Shannon Thyme Klinger, Chief Legal Officer at Moderna, Inc. (MRNA), sold 2,638 shares at $79.39 ($209K) on 2024-08-28, disclosed to the SEC on 2024-08-29.
Scheduled sale ($209k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.39 | 1,319 | $105K | 50.0% |
| 2 | $79.39 | 1,319 | $105K | 50.0% |
| Total | $79.39 avg | 2,638 | $209K | 100% |
| Filing → |
| MRNA | SELL | 2026-03-03 | $726K | — | Filing → |
| MRNA | SELL | 2024-12-10 | $24K | — | Filing → |
| MRNA | SELL | 2024-12-04 | $5K | — | Filing → |